April 2021 - Online Technical Meeting

Meeting objectives

  • Increasing access to HPV vaccination 

- Discuss experiences and opportunities to sustain/reinforce/implement HPV vaccination in different regions across the world, in general and during the Covid-19 pandemic.
- Discuss innovations that may help to achieve access targets such as, improved vaccination schedules, single dose, training and communication of Health Care Workers, etc.
- Review successful country examples with increased access to vaccination and high vaccination coverage.
- Discuss need for future research and trials.
- Discuss lessons learnt from Covid-19 and how these opportunities can be leveraged to increase access to vaccination. 

  • Increasing access to cervical cancer screening and treatment 

- Discuss experiences and opportunities to sustain/reinforce/implement screening and treatment programs across different regions in the world, in general and during the Covid-19 pandemic.
- Discuss innovations that may help to achieve access targets such as, self-sampling, availability of HPV tests, point of care screening technology, artificial intelligence-based screening, digitally reaching out to women, etc.
- Review successful country examples with increased access to screening and treatment.
- Discuss need for future research and trials.
- Discuss lessons learnt from Covid-19 and how to leverage these opportunities to increase access to cervical cancer screening and treatment.

Background document

Thursday, 15 April 2021 

SESSION 1: OPENING AND OBJECTIVES 

  • Welcome & Introduction 
    Alex Vorsters (University of Antwerp) 
    (Pdf, Video

SESSION 2A: SUSTAINING/REINFORCING HPV VACCINATION
Chairs: Suzanne Garland & Liudmila Mosina 

  • Strategies used during Covid-19 and re-starting HPV vaccinationProgram in England
    Joanne Yarwood (Public Health England) 
    (Pdf, Video)

  • Getting HPV vaccination back on track in the US & Update on National HPV Vaccination Roundtable’s efforts
    Noel Brewer (University of North Carolina) 
    (Pdf, Video)

  • Regaining vaccine coverage in Colombia – lessons learnt
    Xavier Bosch (Institut Català d'Oncologia)  (Pdf, Video)
    Carlos Castro (Colombian League Against Cancer) (Pdf, Video

  • Questions & Discussions (Video)​

SESSION 2B: FUTURE APPROACHES FOR HPV VACCINATION
Chairs: Paul Bloem & Iacopo Baussano 

  • One dose – current status and findings
    Aimee Kreimer (NCI) 
    (Pdf, Video

  • HPV extended second dose – current status and findings
    Chantal Sauvageau (Quebec National Public Health Institute) 
    (Pdf, Video)

  • Questions & discussions (Video)​

  • Are countries improving their HPV vaccination coverage? A trend analysis of WHO HPV vaccination coverage estimates 2010-2019
    Laia Bruni (Institut Català d'Oncologia) 
    (Pdf, Video)

  • Questions & discussion (Video)​


SESSION 3: LESSONS LEARNT FROM COVID-19: LEVERAGING OPPORTUNITIES FOR HPV VACCINATION 
Chair: Susanne Krüger Kjaer  

  • HPV vaccine acceptance in a time of Covid-19
    Heidi Larson (Vaccine Confidence Project LSHTM) 
    (Pdf, Video

  • Lessons learned during deployment of a new smartphone-based safety monitoring system
    Tanya Myers (CDC) 
    (Pdf, Video)

  • Questions & Discussions (Video)​

SESSION 4: BREAKOUT SESSION 

  • Breakout Sessions (All participants)
    Chairs: Narendra Kumar Arora, Anna Giuliano & Silvia de Sanjosé

  • Topics:
    - Lessons Learnt and Way Forward
    - Sharing HPV vaccination programs experiences 

  • Plenary feedback & Concluding points (Video)​

Friday, 16 April 2021 

INTRODUCTION

  • Welcome & Introduction
    Alex Vorsters (University of Antwerp) 
    (Pdf, Video)

SESSION 5A: Re-STARTING/REINFORCING CERVICAL CANCER SCREENING AND TREATMENT PROGRAMS 
Chairs: Jack Cuzick & Murat Gultekin 

  • Impact of Covid-19 on cervical cancer screening programmes in LMICs
    Partha Basu (IARC)
    (Pdf, Video)

  • Short Update on cervical cancer screening programs and trials
    Yin Lin Woo (Malaysia) (Video
    Alejandra Castanon (England) (Video)
    Sharon Hanley (Japan) (Pdf, Video)
    Maribel Almonte (ESTAMPA study) (Pdf, Video)

  • Question & Discussions (Video)​

SESSION 5B: OPPORTUNITIES FOR CO-TESTING (HIV & HPV)
Chairs: Somesh Kumar & Alex Vorsters

  • Opportunities for co-testing (HIV & HPV): reinforcing access
    Julie Torode (UICC) (Pdf, Video)
    Lisa Huang (Expertise France) (Pdf, Video)

  • Question & Discussions (Video)​

SESSION 6: LESSONS LEARNT FROM COVID-19: LEVERAGING OPPORTUNITIES FOR CERVICAL CANCER SCREENING AND TREATMENT
Chairs: Marc Arbyn & Partha Basu 

  • Impact of Covid-19 testing on HPV testing
    Mario Poljak (University of Ljubljana) 
    (Pdf, Video)

  • Use of self-sampling for triage
    Jack Cuzick (Wolfson Institute of Preventive Medicine in London) 
    (Pdf, Video)

    Use of AI for cervical cancer testing and treatment

  • Use of AI for cervical cancer screening
    Silvia de Sanjosé (NCI, PATH) & 
    Kanan Desai (NCI)
    (Pdf, Video)

  • New Generation Colposcopies and the role of AI
    Murat Gultekin (Hacettepe University Hospitals) 
    (Pdf)

  • Questions & Discussion (Video)​

SESSION 7: BREAKOUT SESSION 

  • Breakout session
    Chairs: Mario Poljak & Eduardo Franco

  • - Discuss need for future research and trials.
    - Steps for reinforcing cervical cancer screening
    - Steps for reinforcing HPV vaccination 

  • Plenary feedback (Video)​

SESSION 8: CONCLUSION
Chair: Alex Vorsters 

  • Conclusions and Concluding remarks
    Marc Baay (P95) & Alex Vorsters (University of Antwerp)
    (Video